GHRS - GH Research PLC

QQQ $ 441.33 $ 0.96 (0.22 %)

DIA $ 394.43 $ 3.52 (0.9 %)

SPY $ 520.56 $ 2.98 (0.58 %)

TLT $ 90.69 $ 0.44 (0.49 %)

GLD $ 216.93 $ 3.37 (1.58 %)

Previous Close

$ 11.99

Open

$ 11.95

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 11.95 - $ 12.10

52 Week Range

$ 5.05 - $ 14.64

Volume

60,392

Average Volume

Market Cap

623.82M

Beta (5Y Monthly)

$ 1.03

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on GH R...
05/07/2024 17:45:51

HC Wainwright & Co. analyst Patrick Trucchio reiterates GH Research (NASDAQ:GHRS) with a Buy and maintains $40 price tar...

Canaccord Genuity Maintains Buy on GH Rese...
05/06/2024 17:32:30

Canaccord Genuity analyst Sumant Kulkarni maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $3...

GH Research Q1 EPS $(0.15) Beats $(0.22) E...
05/03/2024 11:07:56

GH Research (NASDAQ:GHRS) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.22) b...

psyched-dea-revisits-ban-on-two-psychedelics-farewell-russell-newcombe-podcast-episode-on-kanna--more

Psyched: DEA Revisits Ban On Two Psychedel...
04/17/2024 12:42:33

psyched-5-meo-dmt-for-depression-utah-hospitals-providing-therapy-elon-musk-and-metas-influence

Psyched: 5-MeO-DMT For Depression, Utah Ho...
03/29/2024 16:43:17

psyched-lsd-psilocybin-as-breakthrough-therapies-14m-fed-grant-for-ibogaine-indianas-research-and-more

Psyched: LSD, Psilocybin As Breakthrough T...
03/20/2024 18:49:36

psyched-new-evidence-shows-psilocybin-as-anxiety-therapy-open-source-learning-for-therapists-enverics-licensing-deals-and-more

Psyched: New Evidence Shows Psilocybin As ...
03/04/2024 18:48:15

HC Wainwright & Co. Reiterates Buy on GH R...
03/04/2024 18:08:42

HC Wainwright & Co. analyst Patrick Trucchio reiterates GH Research (NASDAQ:GHRS) with a Buy and maintains $40 price tar...

JMP Securities Maintains Market Outperform...
03/01/2024 16:52:02

JMP Securities analyst Jason Butler maintains GH Research (NASDAQ:GHRS) with a Market Outperform and lowers the price target...

gh-research-this-european-biotech-company-reports-full-year-2023-financial-results-and-business-updates

GH Research: This European Biotech Company...
03/01/2024 03:47:33

GH Research: Q4 Earnings Insights
02/29/2024 13:00:26

GH Research Reports FY23 Net Loss Of $(35....
02/29/2024 12:19:25

psyched-psychedelics--sex-mdma-and-federal-approval-canadians-for-end-of-life-care-and-more

Psyched: Psychedelics & Sex, MDMA And Fede...
02/15/2024 13:36:47

psyched-suggestibility-and-psychedelics-effects-eus-7m-research-fund-australias-treatment-delivery-bz-podcast-and-more

Psyched: Suggestibility And Psychedelics' ...
01/27/2024 15:00:18

New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedel...

psychedelics-headlines-anti-inflammatory-effects-global-drug-survey-synthetic-surprise-uks-harm-reduction-hub-and-more

Psychedelics Headlines: Anti-inflammatory ...
01/26/2024 17:33:24

Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and onli...

GH Research Announces Grant Of European Pa...
01/18/2024 21:31:54

HC Wainwright & Co. Reiterates Buy on GH R...
01/18/2024 11:14:23

HC Wainwright & Co. analyst Patrick Trucchio reiterates GH Research (NASDAQ:GHRS) with a Buy and maintains $40 price tar...

psyched-100m-for-mdma-therapy-va-funds-2024-watchlist-reform-updates-and-more

Psyched: $100M For MDMA Therapy, VA Funds,...
01/12/2024 21:55:40

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

psyched-psychedelics-for-brain-injury-kentucky-initiative-stalled-dea-quotas-insurance-codes-50m-for-atai-and-more

Psyched: Psychedelics For Brain Injury, Ke...
01/08/2024 19:33:34

Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury

atai-invests-50m-in-beckley-psytech-for-short-duration-psychedelics-development

Atai Invests $50M In Beckley Psytech For S...
01/04/2024 19:17:46

Biopharma and resources-pooling company Atai Life Sciences (NASDAQ: ATAI) has invested a total of $50 million in Beckley Psytec...